Psychosis
Research Study
Researchers at Beth Israel Deaconess Medical Center are partnering with adults diagnosed with schizophrenia to investigate how Transcranial Magnetic Stimulation can reduce psychiatric symptoms. Join our study today!
Fast Facts
18-65 Years Old
Diagnosed with schizophrenia or schizoaffective Disorder
No metal implants in head or seizure disorder
Compensation up to $1600 Provided
conducted in boston, MA
Study Background
Researchers at Beth Israel Deaconess Medical Center (BIDMC) are conducting a research study to reduce symptoms of psychosis through the use of Transcranial Magnetic Stimulation (TMS).
Findings from this clinical research study will determine how TMS, a non-invasive way of stimulating the brain, can reduce symptoms associated with psychotic disorders. Symptoms of schizophrenia and schizoaffective disorder may include hallucinations, delusions, and difficulties with thinking.
This study involves an MRI scan, clinical interviews, behavioral and cognitive testing, and TMS treatments. Participants will receive five days of TMS treatments, followed by a one week, three week, and six month follow-up visit.
Further research today and join our study!
Study Background
Researchers at Beth Israel Deaconess Medical Center (BIDMC) are conducting a research study to reduce symptoms of psychosis through the use of Transcranial Magnetic Stimulation (TMS).
Findings from this clinical research study will determine how TMS, a non-invasive way of stimulating the brain, can reduce symptoms associated with psychotic disorders. Symptoms of schizophrenia and schizoaffective disorder may include hallucinations, delusions, and difficulties with thinking.
This study involves an MRI scan, clinical interviews, behavioral and cognitive testing, and TMS treatments. Participants will receive five days of TMS treatments, followed by a one week, three week, and six month follow-up visit.
Further research today and join our study!
Additional Information
You may qualify for this study if you meet the following criteria:
Key Criteria:
- 18-65 years old
- Diagnosed with schizophrenia or schizoaffective disorder
- No medication changes or hospitalizations for psychiatric symptoms in the past month
- Have stable outpatient treatment
- No metal implants in your head or seizure disorder
Once enrolled, this study involves:
- Undergoing an MRI scan
- Completing clinical interviews, and behavioral and cognitive testing
- Receiving one week (5 days) of TMS treatments
- Attending one week, three week, and 6-month follow-up visits
